Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Whittle, AT; Davis, M; Shovlin, CL; Ganly, PS; Haslett, C; Greening, AP
   Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantation
   THORAX
   
   A.T. Whittle et al., "Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantation", THORAX, 56(12), 2001, pp. 941-946
2. Crompton, GK; Sanderson, R; Dewar, MH; Matusiewicz, SP; Ning, ACWS; Jamieson, AH; McLean, A; Greening, AP
   Comparison of Pulmicort (R) pMDI plus Nebuhaler (R) and Pulmicort (R) Turbuhaler (R) in asthmatic patients with dysphonia
   RESPIRATORY MEDICINE
   
   G.K. Crompton et al., "Comparison of Pulmicort (R) pMDI plus Nebuhaler (R) and Pulmicort (R) Turbuhaler (R) in asthmatic patients with dysphonia", RESP MED, 94(5), 2000, pp. 448-453
3. Simpson, AJ; Matusiewicz, SP; Greening, AP; Crompton, GK
   Pet ownership and asthma morbidity
   RESPIRATORY MEDICINE
   
   A.J. Simpson et al., "Pet ownership and asthma morbidity", RESP MED, 94(1), 2000, pp. 91-92
4. Ho, LP; Wood, FT; Robson, A; Innes, JA; Greening, AP
   The current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre
   EUROPEAN RESPIRATORY JOURNAL
   
   L.P. Ho et al., "The current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre", EUR RESP J, 15(6), 2000, pp. 1009-1013
5. Cunningham, S; McColm, JR; Ho, LP; Greening, AP; Marshall, TG
   Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis
   EUROPEAN RESPIRATORY JOURNAL
   
   S. Cunningham et al., "Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis", EUR RESP J, 15(5), 2000, pp. 955-957
6. Simpson, AJ; Matusiewicz, SP; Brown, PH; McCall, IA; Innes, JA; Greening, AP; Crompton, GK
   Emergency pre-hospital management of patients admitted with acute asthma
   THORAX
   
   A.J. Simpson et al., "Emergency pre-hospital management of patients admitted with acute asthma", THORAX, 55(2), 2000, pp. 97-101
7. Ho, LP; Wood, FT; Robson, A; Innes, JA; Greening, AP
   Atopy influences exhaled nitric oxide levels in adult asthmatics
   CHEST
   
   L.P. Ho et al., "Atopy influences exhaled nitric oxide levels in adult asthmatics", CHEST, 118(5), 2000, pp. 1327-1331
8. Ho, LP; Faccenda, J; Innes, JA; Greening, AP
   Expired hydrogen peroxide in breath condensate of cystic fibrosis patients
   EUROPEAN RESPIRATORY JOURNAL
   
   L.P. Ho et al., "Expired hydrogen peroxide in breath condensate of cystic fibrosis patients", EUR RESP J, 13(1), 1999, pp. 103-106
9. Bollert, FGE; Paton, JY; Marshall, TG; Calvert, J; Greening, AP; Innes, JA
   Recombinant DNase in cystic fibrosis: a protocol for targeted introductionthrough n-of-1 trials
   EUROPEAN RESPIRATORY JOURNAL
   
   F.G.E. Bollert et al., "Recombinant DNase in cystic fibrosis: a protocol for targeted introductionthrough n-of-1 trials", EUR RESP J, 13(1), 1999, pp. 107-113
10. Whittle, AT; Davis, M; Johnson, PRE; Leonard, RCF; Greening, AP
    The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia
    BONE MARROW TRANSPLANTATION
    
    A.T. Whittle et al., "The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia", BONE MAR TR, 24(1), 1999, pp. 63-67
11. Cushley, MJ; Davison, AG; du Bois, RM; Egan, J; Flower, CDR; Gibson, GJ; Greening, AP; Ibrahim, NBN; Johnston, IDA; Mitchell, DM; Pickering, CAC
    The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults
    THORAX
    
    M.J. Cushley et al., "The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults", THORAX, 54, 1999, pp. S1-S30
12. RODGERS HC; LIDDLE K; NIXON SJ; INNES JA; GREENING AP
    TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES IN CYSTIC-FIBROSIS - COMPLICATIONS AND PATIENTS OPINIONS
    The European respiratory journal
    
    H.C. Rodgers et al., "TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES IN CYSTIC-FIBROSIS - COMPLICATIONS AND PATIENTS OPINIONS", The European respiratory journal, 12(1), 1998, pp. 217-220
13. Ho, LP; Innes, JA; Greening, AP
    Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis
    EUROPEAN RESPIRATORY JOURNAL
    
    L.P. Ho et al., "Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis", EUR RESP J, 12(6), 1998, pp. 1290-1294
14. HO LP; INNES JA; GREENING AP
    NITRITE LEVELS IN BREATH CONDENSATE OF PATIENTS WITH CYSTIC-FIBROSIS IS ELEVATED IN CONTRAST TO EXHALED NITRIC-OXIDE
    Thorax
    
    L.P. Ho et al., "NITRITE LEVELS IN BREATH CONDENSATE OF PATIENTS WITH CYSTIC-FIBROSIS IS ELEVATED IN CONTRAST TO EXHALED NITRIC-OXIDE", Thorax, 53(8), 1998, pp. 680-684
15. ROSSI AG; HASLETT C; HIRANI N; GREENING AP; RAHMAN I; METZ CN; BUCALA R; DONNELLY SC
    HUMAN CIRCULATING EOSINOPHILS SECRETE MACROPHAGE-MIGRATION INHIBITORYFACTOR (MIF) - POTENTIAL ROLE IN ASTHMA
    The Journal of clinical investigation
    
    A.G. Rossi et al., "HUMAN CIRCULATING EOSINOPHILS SECRETE MACROPHAGE-MIGRATION INHIBITORYFACTOR (MIF) - POTENTIAL ROLE IN ASTHMA", The Journal of clinical investigation, 101(12), 1998, pp. 2869-2874
16. PORTEOUS DJ; DORIN JR; MCLACHLAN G; DAVIDSONSMITH H; DAVIDSON H; STEVENSON BJ; CAROTHERS AD; WALLACE WAH; MORALEE S; HOENES C; KALLMEYER G; MICHAELIS U; NAUJOKS K; HO LP; SAMWAYS JM; IMRIE M; GREENING AP; INNES JA
    EVIDENCE FOR SAFETY AND EFFICACY OF DOTAP CATIONIC LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS
    Gene therapy
    
    D.J. Porteous et al., "EVIDENCE FOR SAFETY AND EFFICACY OF DOTAP CATIONIC LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS", Gene therapy, 4(3), 1997, pp. 210-218
17. FROEBEL KS; BOLLERT FGE; JELLEMA J; BIRD AG; GREENING AP
    IMMUNODEFICIENCY IN NONTUBERCULOUS MYCOBACTERIAL DISEASE
    Respiratory medicine
    
    K.S. Froebel et al., "IMMUNODEFICIENCY IN NONTUBERCULOUS MYCOBACTERIAL DISEASE", Respiratory medicine, 91(2), 1997, pp. 95-101
18. GREENING AP
    CLINICAL ISSUES IN THE TREATMENT OF ADULT ASTHMA
    Respiratory medicine
    
    A.P. Greening, "CLINICAL ISSUES IN THE TREATMENT OF ADULT ASTHMA", Respiratory medicine, 91, 1997, pp. 38-39
19. HO LP; SAMWAYS JM; PORTEOUS DJ; DORIN DJ; CAROTHERS A; GREENING AP; INNES JA
    CORRELATION BETWEEN NASAL POTENTIAL DIFFERENCE MEASUREMENTS, GENOTYPEAND CLINICAL CONDITION IN PATIENTS WITH CYSTIC-FIBROSIS
    The European respiratory journal
    
    L.P. Ho et al., "CORRELATION BETWEEN NASAL POTENTIAL DIFFERENCE MEASUREMENTS, GENOTYPEAND CLINICAL CONDITION IN PATIENTS WITH CYSTIC-FIBROSIS", The European respiratory journal, 10(9), 1997, pp. 2018-2022
20. BOLLERT FGE; MATUSIEWICZ SP; DEWAR MH; BROWN GM; MCLEAN A; GREENING AP; CROMPTON GK
    COMPARATIVE EFFICACY AND POTENCY OF IPRATROPIUM VIA TURBUHALER(R) ANDPRESSURIZED METERED-DOSE INHALER IN REVERSIBLE AIR-FLOW OBSTRUCTION
    The European respiratory journal
    
    F.G.E. Bollert et al., "COMPARATIVE EFFICACY AND POTENCY OF IPRATROPIUM VIA TURBUHALER(R) ANDPRESSURIZED METERED-DOSE INHALER IN REVERSIBLE AIR-FLOW OBSTRUCTION", The European respiratory journal, 10(8), 1997, pp. 1824-1828
21. GREENING AP
    PLACE OF LONG-ACTING BETA-AGONISTS IN ASTHMA NOT CONTROLLED BY CORTICOSTEROIDS
    CLINICAL IMMUNOTHERAPEUTICS
    
    A.P. Greening, "PLACE OF LONG-ACTING BETA-AGONISTS IN ASTHMA NOT CONTROLLED BY CORTICOSTEROIDS", CLINICAL IMMUNOTHERAPEUTICS, 5(6), 1996, pp. 438-448
22. MCLACHLAN G; HO LP; DAVIDSONSMITH H; SAMWAYS J; DAVIDSON H; STEVENSON BJ; CAROTHERS AD; ALTON EWFW; MIDDLETON PG; SMITH SN; KALLMEYER G; MICHAELIS U; SEEBER S; NAUJOKS K; GREENING AP; INNES JA; DORIN JR; PORTEOUS DJ
    LABORATORY AND CLINICAL-STUDIES IN SUPPORT OF CYSTIC-FIBROSIS GENE-THERAPY USING PCMV-CFTR-DOTAP
    Gene therapy
    
    G. Mclachlan et al., "LABORATORY AND CLINICAL-STUDIES IN SUPPORT OF CYSTIC-FIBROSIS GENE-THERAPY USING PCMV-CFTR-DOTAP", Gene therapy, 3(12), 1996, pp. 1113-1123
23. BARNES PJ; GREENING AP; CROMPTON GK
    GLUCOCORTICOID RESISTANCE IN ASTHMA
    American journal of respiratory and critical care medicine
    
    P.J. Barnes et al., "GLUCOCORTICOID RESISTANCE IN ASTHMA", American journal of respiratory and critical care medicine, 152(6), 1995, pp. 125-140
24. WILLIAMSON IJ; MATUSIEWICZ SP; BROWN PH; GREENING AP; CROMPTON GK
    FREQUENCY OF VOICE PROBLEMS AND COUGH IN PATIENTS USING PRESSURIZED AEROSOL INHALED STEROID PREPARATIONS
    The European respiratory journal
    
    I.J. Williamson et al., "FREQUENCY OF VOICE PROBLEMS AND COUGH IN PATIENTS USING PRESSURIZED AEROSOL INHALED STEROID PREPARATIONS", The European respiratory journal, 8(4), 1995, pp. 590-592
25. BROWN PH; NING ACWS; GREENING AP; MCLEAN A; CROMPTON GK
    PEAK INSPIRATORY FLOW-THROUGH TURBUHALER(R) IN ACUTE ASTHMA
    The European respiratory journal
    
    P.H. Brown et al., "PEAK INSPIRATORY FLOW-THROUGH TURBUHALER(R) IN ACUTE ASTHMA", The European respiratory journal, 8(11), 1995, pp. 1940-1941
26. BOLLERT FGE; WATT B; GREENING AP; CROMPTON GK
    NONTUBERCULOUS PULMONARY INFECTIONS IN SCOTLAND - A CLUSTER IN LOTHIAN
    Thorax
    
    F.G.E. Bollert et al., "NONTUBERCULOUS PULMONARY INFECTIONS IN SCOTLAND - A CLUSTER IN LOTHIAN", Thorax, 50(2), 1995, pp. 188-190
27. MATUSIEWICZ SP; FERGUSSON RJ; GREENING AP; CROMPTON GK; BURNS SM
    PNEUMOCYSTIS-CARINII IN BRONCHOALVEOLAR LAVAGE FLUID AND BRONCHIAL WASHINGS
    BMJ. British medical journal
    
    S.P. Matusiewicz et al., "PNEUMOCYSTIS-CARINII IN BRONCHOALVEOLAR LAVAGE FLUID AND BRONCHIAL WASHINGS", BMJ. British medical journal, 308(6938), 1994, pp. 1206-1207
28. GREENING AP
    CLINICAL-TRIALS OF HIGH-DOSE FLUTICASONE PROPIONATE
    Respiratory medicine
    
    A.P. Greening, "CLINICAL-TRIALS OF HIGH-DOSE FLUTICASONE PROPIONATE", Respiratory medicine, 88, 1994, pp. 17-23
29. GREENING AP; IND PW; NORTHFIELD M; SHAW G
    ADDED SALMETEROL VERSUS HIGHER-DOSE CORTICOSTEROID IN ASTHMA PATIENTSWITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID
    Lancet
    
    A.P. Greening et al., "ADDED SALMETEROL VERSUS HIGHER-DOSE CORTICOSTEROID IN ASTHMA PATIENTSWITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID", Lancet, 344(8917), 1994, pp. 219-224
30. INNES JA; GREENING AP; WEBB K
    HIGH-STRENGTH PANCREATIC-ENZYMES
    Lancet
    
    J.A. Innes et al., "HIGH-STRENGTH PANCREATIC-ENZYMES", Lancet, 343(8897), 1994, pp. 599-599
31. WALLACE WAH; ROBERTS SN; CALDWELL H; THORNTON E; GREENING AP; LAMB D; HOWIE SEM
    CIRCULATING ANTIBODIES TO LUNG PROTEIN(S) IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS
    Thorax
    
    W.A.H. Wallace et al., "CIRCULATING ANTIBODIES TO LUNG PROTEIN(S) IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS", Thorax, 49(3), 1994, pp. 218-224
32. MACKAY TW; WALLACE WAH; HOWIE SEM; BROWN PH; GREENING AP; CHURCH MK; DOUGLAS NJ
    ROLE OF INFLAMMATION IN NOCTURNAL ASTHMA
    Thorax
    
    T.W. Mackay et al., "ROLE OF INFLAMMATION IN NOCTURNAL ASTHMA", Thorax, 49(3), 1994, pp. 257-262
33. BROWN P; GREENING AP; CROMPTON GK
    HYPOTHALAMO-PITUITARY-ADRENAL AXIS SUPPRESSION IN ASTHMATICS - REPLY
    Respiratory medicine
    
    P. Brown et al., "HYPOTHALAMO-PITUITARY-ADRENAL AXIS SUPPRESSION IN ASTHMATICS - REPLY", Respiratory medicine, 87(4), 1993, pp. 321-321
34. MATUSIEWICZ SP; WILLIAMSON IJ; SIME PJ; BROWN PH; WENHAM PR; CROMPTON GK; GREENING AP
    PLASMA LACTATE-DEHYDROGENASE - A MARKER OF DISEASE-ACTIVITY IN CRYPTOGENIC FIBROSING ALVEOLITIS AND EXTRINSIC ALLERGIC ALVEOLITIS
    The European respiratory journal
    
    S.P. Matusiewicz et al., "PLASMA LACTATE-DEHYDROGENASE - A MARKER OF DISEASE-ACTIVITY IN CRYPTOGENIC FIBROSING ALVEOLITIS AND EXTRINSIC ALLERGIC ALVEOLITIS", The European respiratory journal, 6(9), 1993, pp. 1282-1286
35. GOVAN JRW; BROWN PH; MADDISON J; DOHERTY CJ; NELSON JW; DODD M; GREENING AP; WEBB AK
    EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT INCYSTIC-FIBROSIS
    Lancet
    
    J.R.W. Govan et al., "EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT INCYSTIC-FIBROSIS", Lancet, 342(8862), 1993, pp. 15-19
36. BROWN PH; MATUSIEWICZ SP; SHEARING C; TIBI L; GREENING AP; CROMPTON GK
    SYSTEMIC EFFECTS OF HIGH-DOSE INHALED STEROIDS - COMPARISON OF BECLOMETHASONE DIPROPIONATE AND BUDESONIDE IN HEALTHY-SUBJECTS
    Thorax
    
    P.H. Brown et al., "SYSTEMIC EFFECTS OF HIGH-DOSE INHALED STEROIDS - COMPARISON OF BECLOMETHASONE DIPROPIONATE AND BUDESONIDE IN HEALTHY-SUBJECTS", Thorax, 48(10), 1993, pp. 967-973
37. NELSON JW; BUTLER SL; BROWN PH; GREENING AP; GOVAN JRW
    SERUM IGG AND SPUTUM IGA ANTIBODY TO CORE LIPOPOLYSACCHARIDE ANTIGEN FROM PSEUDOMONAS-CEPACIA IN PATIENTS WITH CYSTIC-FIBROSIS
    Journal of Medical Microbiology
    
    J.W. Nelson et al., "SERUM IGG AND SPUTUM IGA ANTIBODY TO CORE LIPOPOLYSACCHARIDE ANTIGEN FROM PSEUDOMONAS-CEPACIA IN PATIENTS WITH CYSTIC-FIBROSIS", Journal of Medical Microbiology, 39(1), 1993, pp. 39-47
38. TUOHY MB; BAIN MH; GREENING AP
    HYPOXIA PRIMES RAT ALVEOLAR MACROPHAGES FOR ENHANCED STIMULATED RELEASE OF HYDROGEN-PEROXIDE
    The American review of respiratory disease
    
    M.B. Tuohy et al., "HYPOXIA PRIMES RAT ALVEOLAR MACROPHAGES FOR ENHANCED STIMULATED RELEASE OF HYDROGEN-PEROXIDE", The American review of respiratory disease, 147(4), 1993, pp. 68-68
39. BROWN PH; MATUSIEWICZ SP; WALLACE WAH; HOWIE SEM; RAMAGE E; CROMPTON GK; LAMB DL; GREENING AP
    BRONCHIAL INFLAMMATION IN CORTICOSTEROID-SENSITIVE (CS) AND CORTICOSTEROID-RESISTANT (CR) ASTHMA
    The American review of respiratory disease
    
    P.H. Brown et al., "BRONCHIAL INFLAMMATION IN CORTICOSTEROID-SENSITIVE (CS) AND CORTICOSTEROID-RESISTANT (CR) ASTHMA", The American review of respiratory disease, 147(4), 1993, pp. 521-521
40. MATUSIEWICZ SP; WALLACE WAH; HOWIE SEM; GREENING AP
    BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION MARKERS IN PATIENTS WITH MODERATE SEVERE SYMPTOMATIC ASTHMA/
    The American review of respiratory disease
    
    S.P. Matusiewicz et al., "BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION MARKERS IN PATIENTS WITH MODERATE SEVERE SYMPTOMATIC ASTHMA/", The American review of respiratory disease, 147(4), 1993, pp. 561-561
41. MATUSIEWICZ SP; BROWN PH; CROMPTON GK; GREENING AP
    SAFETY OF FIBEROPTIC BRONCHOSCOPY FOR RESEARCH IN PATIENTS WITH SEVERE CHRONIC ASTHMA
    The American review of respiratory disease
    
    S.P. Matusiewicz et al., "SAFETY OF FIBEROPTIC BRONCHOSCOPY FOR RESEARCH IN PATIENTS WITH SEVERE CHRONIC ASTHMA", The American review of respiratory disease, 147(4), 1993, pp. 564-564
42. MATUSIEWICZ SP; BROWN PH; GORDON M; GREENING AP
    ALVEOLAR MACROPHAGE CYTOKINE GENERATION IN SEVERE CHRONIC BRONCHIAL-ASTHMA
    The American review of respiratory disease
    
    S.P. Matusiewicz et al., "ALVEOLAR MACROPHAGE CYTOKINE GENERATION IN SEVERE CHRONIC BRONCHIAL-ASTHMA", The American review of respiratory disease, 147(4), 1993, pp. 786-786
43. MATUSIEWICZ SP; DEWAR M; HOWIE SEM; GREENING AP
    SALMETEROL THERAPY FOR SEVERE NOCTURNAL ASTHMA DOES NOT INFLUENCE BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION
    The American review of respiratory disease
    
    S.P. Matusiewicz et al., "SALMETEROL THERAPY FOR SEVERE NOCTURNAL ASTHMA DOES NOT INFLUENCE BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION", The American review of respiratory disease, 147(4), 1993, pp. 980-980